Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains.
Iron, a transition metal possibly involved in the pathogenesis of Parkinson's disease, was tested for its toxic effects toward cultures of dissociated rat mesencephalic cells. When cultures were switched for 24 h to serum-free conditions, the effective concentrations of ferrous iron (Fe2+) producing a loss of 50% of dopaminergic neurons, as quantified by tyrosine hydroxylase (TH) immunocytochemistry, TH mRNA in situ hybridization, and measurement of TH activity, were on the order of 200 microM. High-affinity dopamine (DA) uptake, which reflects integrity and function of dopaminergic nerve terminals, was impaired at significantly lower concentrations (EC50 = 67 microM). Toxic effects were not restricted to dopaminergic neurons inasmuch as trypan blue dye exclusion index and gamma-aminobutyric acid uptake, two parameters used to assess survival of other types of cells present in these cultures, were also affected. Protection against iron cytotoxicity was afforded by desferrioxamine and apotransferrin, two ferric iron-chelating agents. Normal supplementation of the culture medium by serum proteins during treatment was also effective, presumably via nonspecific sequestration. Potential interactions with DA were also investigated. Fe2+ at subtoxic concentrations and desferrioxamine in the absence of exogenous iron added to the cultures failed to potentiate or reduce DA cytotoxicity for mesencephalic cells, respectively. Transferrin, the glycoprotein responsible for intracellular delivery of iron, was ineffective in initiating selective cytotoxic effects toward dopaminergic neurons preloaded with DA. Altogether, these results suggest (a) that ferrous iron is a potent neurotoxin for dopaminergic neurons as well as for other cell types in dissociated mesencephalic cultures, acting likely via autoxidation into its ferric form, and (b) that the presence of intra- and extracellular DA is not required for the observed toxic effects.
Michel
P P
PP
INSERM U. 289, Hôpital de la Salpêtrière, Paris, France.
Vyas
S
S
Agid
Y
Y
D000818:Animals; D001921:Brain / Q000196:embryology*; D016923:Cell Death; D002478:Cells, Cultured; D003470:Culture Media; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D004622:Embryo, Mammalian / Q000187:drug effects*; D007425:Intracellular Membranes / Q000378:metabolism; D007501:Iron / Q000032:analysis / Q000506:poisoning*; D008636:Mesencephalon / Q000166:cytology* / Q000201:enzymology / Q000378:metabolism; D009474:Neurons / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D014168:Transferrin / Q000494:pharmacology
D003470:Culture Media; D014168:Transferrin; D007501:Iron; D004298:Dopamine